Articole recomandate
The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthriti
Autori: Binstadt BA, Nigrovic PA.Arthritis Rheumatol. 2022 Jul;74(7):1122-1131. doi: 10.1002/art.42137.
Role for Granulocyte Colony-Stimulating Factor in Neutrophilic Extramedullary Myelopoiesis in a Murine Model of Systemic Juvenile Idiopathic Arthritis
Autori: Malengier-Devlies B, Bernaerts E, Ahmadzadeh K, Filtjens J, Vandenhaute J, Boeckx B, Burton O, De Visscher A, Mitera T, Berghmans N, Verbeke G, Liston A, Lambrechts D, Proost P, Wouters C, Matthys P.
Arthritis Rheumatol. 2022 Jul;74(7):1257-1270. doi: 10.1002/art.42104.
Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis
Autori: Chen G, Deutsch GH, Schulert GS, Zheng H, Jang S, Trapnell B, Lee PY, Macaubas C, Ho K, Schneider C, Saper VE, de Jesus AA, Krasnow MA, Grom A, Goldbach-Mansky R, Khatri P, Mellins ED, Canna SW.
Arthritis Rheumatol. 2022 Jul;74(7):1271-1283. doi: 10.1002/art.42099.
Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment
Autori: Sukharomana M, Udomittipong K, Ruangchira-Urai R, Charuvanij S.
Asian Pac J Allergy Immunol. 2022 Jun;40(2):172-176. doi: 10.12932/AP-050819-0616.
MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever
Autori: Park C, Miranda-Garcia M, Berendes R, Horneff G, Kuemmerle-Deschner J, Ganser G, Huppertz HI, Minden K, Haas JP, Jansson AF, Borte M, Schuetz C, Oommen P, Frosch M, Schlueter B, Richter-Unruh A, Kessel C, Hinze C,ittkowski H, Roth J, Foell D, Holzinger D.
Rheumatology (Oxford). 2022 Jul 6;61(7):3082-3092. doi: 10.1093/rheumatology/keab729.
Systemic Juvenile Idiopathic Arthritis in two children; case report on clinical course, challenges in diagnosis and the role of FDG-PET/CT-scan
Autori: Sahba S, Huurnink A, Van den Berg JM, Tuitert B, Vastert SJ, Ten Tusscher GW.
Clin Case Rep.2022 Jun 13;10(6):e05900. doi: 10.1002/ccr3.5900. eCollection 2022 Jun.
Adult-Onset and Juvenile-Onset Still’s Disease: A comparative study of both sides
Autori: Ben Tekaya A, Hannech E, Saidane O, Bouden S, Rouached L, Tekaya R, Mahmoud I, Abdelmoula S, Abdelmoula L.
Curr Rheumatol Rev. 2022 Jun 17. doi: 10.2174/1573397118666220617101447. Online ahead of print.
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
Ferrara G, Mastrangelo G, Barone P si colaboratorii (Pediatric Rheumatology Online Journal. 2018)
Lung Ultrasound in Children with Systemic Juvenile Idiopathic Arthritis Associated Interstitial Lung Disease
Autori: Vega-Fernandez P, Ting TV, Mar DA, Schapiro AH, Deluna MD, Saper VE, Grom AA, Schulert GS, Fairchild RM.
Arthritis Care Res (Hoboken). 2022 May 23. doi: 10.1002/acr.24957. Online ahead of print.
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
Swart JF, et al. Ann Rheum Dis 2017;0:1–7
2017 European League Against Rheumatism/ American College of Rheumatology classification criteria for adult and juvenile idiopathic in ammatory myopathies and their major subgroups
Lundberg IE, et al. Ann Rheum Dis 2017;76:1955–1964.
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative
Groot N, et al. Ann Rheum Dis 2017;76:1965–1973
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative
Groot N, et al. Ann Rheum Dis 2017;76:1788–1796
Ringold S, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
Arthritis Care Res (Hoboken). 2013;65(10):1551-63.
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative
Groot N, et al. Ann Rheum Dis 2017;76:1637–1641
Ringold S et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
Arthritis Rheum. 2013;65(10):2499-512.
DeWitt EM et al. Consensus Treatment Plans for New-Onset Systemic Juvenile Idiopathic Arthritis
Arthritis Care Res (Hoboken). 2012; 64(7): 1001–1010
Li S et al. Development of Consensus Treatment Plans for Juvenile Localized Scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
Arthritis Care Res (Hoboken). 2012; 64(8): 1175–1185
